DGX - Quest Diagnostics Incorporated logo

DGX

Quest Diagnostics Incorporated

Quest Diagnostics provides diagnostic testing and services, including clinical and anatomic pathology testing, to physicians, hospitals, and consumers. It operates a network of laboratories and patient service centers, offering various health solutions.

โš•๏ธ Healthcare NYSE Listed 1996 $ USD
$1,000 invested 20 years ago โ†’$5,352today

Score Overview

1 Year
Score
Net Growth7.06%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth4.76%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.3
Net Growth-46.77%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth7.16%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth64.65%
Net Trend70%
Net Income Consistency
Rev Growth53.83%
Rev Trend70%
Revenue Consistency
20 Years
Score5.7
Net Growth81.10%
Net Trend60%
Net Income Consistency
Rev Growth84.41%
Rev Trend70%
Revenue Consistency
All Time
Score
Net Growth269.66%
Net Trend70%
Net Income Consistency
Rev Growth7x
Rev Trend73%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Quest Diagnostics Incorporated has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. DGX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 237.62โ€”
1 Year2025-09-26
$ 185.7327.94%
5 Years2021-09-28
$ 131.8980.16%
10 Years2016-09-28
$ 69.37242.54%
20 Years2006-09-28
$ 44.40435.22%
All Time1996-12-17
$ 2.4696x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 11.56B$ 1.06B$ 626M
2025$ 11.03B$ 992M$ 420M
2024$ 9.87B$ 871M$ 549M
2023$ 9.25B$ 854M$ 686M
2022$ 9.88B$ 946M$ 315M
2021$ 10.78B$ 1.99B$ 872M
2020$ 9.43B$ 1.43B$ 1.15B
2019$ 7.72B$ 858M$ 1.19B
2018$ 7.53B$ 736M$ 135M
2017$ 7.70B$ 772M$ 137M
2016$ 7.51B$ 645M$ 359M
2015$ 7.49B$ 709M$ 133M
2014$ 7.43B$ 556M$ 192M
2013$ 7.14B$ 849M$ 187M
2012$ 7.38B$ 555M$ 295M
2011$ 7.51B$ 470M$ 164M
2010$ 7.36B$ 720M$ 449M
2009$ 7.45B$ 729M$ 534M
2008$ 7.24B$ 581M$ 253M
2007$ 6.70B$ 339M$ 167M
2006$ 6.26B$ 586M$ 149M
2005$ 5.50B$ 546M$ 92M
2004$ 5.12B$ 499M$ 73M
2003$ 4.73B$ 436M$ 154M
2002$ 4.10B$ 322M$ 96M
2001$ 3.62B$ 162M$ 122M
2000$ 3.42B$ 102M$ 171M
1999$ 2.20B-$ 3M$ 27M
1998$ 1.45B$ 26M$ 202M
1997$ 1.52B-$ 22M$ 161M
IPO1996$ 1.61B-$ 625M$ 41M
DGX - Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated fundamental performance

Between 2005 and 2025, revenue grew from $ 5.50B to $ 11.03B and net income grew from $ 546M to $ 992M. Revenue increased in 14 of those 20 years; net income in 12.

Across Quest Diagnostics Incorporated's full reported history, from 1996 to 2025, revenue grew from $ 1.61B to $ 11.03B and net income went from -$ 625M to $ 992M. Revenue increased in 73% of the years measured; net income in 70%.

Quest Diagnostics Incorporated currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.

Membership

Explore DGX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies